Navigation Links
Children's National Medical Center receives first NIH CTSA given to a children's hospital
Date:7/14/2010

WASHINGTON -- Children's National Medical Center, in partnership with The George Washington University Medical Center, has received a prestigious Clinical and Translational Science Award (CTSA) from the National Center for Research Resources of the National Institutes of Health.

This award, which totals $20 million over five years, is the first CTSA given directly to a children's hospital. The Clinical and Translational Science Institute at Children's National will now join the nationally renowned CTSA consortium, which is composed of institutions that work to transform the local, regional, and national environment to increase the efficiency and speed of clinical and translational research across the country.

Many other CTSA member institutions have research tracks that include pediatric research, but this collaboration will be the first, in the history of the award, to focus specifically on how scientific breakthroughs from the laboratory bench can be brought more quickly and efficiently to the bedsides of young patients locally and around the world. In addition, the institution's close proximity to the nation's capital will bring basic science into community engagement research and health policy applications, making these discoveries accessible for those most in need.

"Both Children's National and The George Washington University have long invested significant resources in investigating and understanding the health needs of the children and families of metropolitan Washington," said Jill Joseph, MD, PhD, principal investigator of the CTSA and Director of the Clinical and Translational Science Institute at Children's National. "The families of our area, and across the country, have already benefited from what we've learned about better clinical treatments and improved community education for common diseases like asthma. We look forward to even greater breakthroughs in providing that care, now bolstered by new research collaborations with consortium institutions."

"Expanding our translational research and development activities, both within the different components at George Washington University and with Children's National Medical Center will provide new educational opportunities for young investigators and deliver cutting edge modalities for patients," said Peter Hotez. MD, PhD, co-principal investigator of the CTSA, GW Distinguished Research Professor, and President of the Sabin Vaccine Institute. "George Washington's expertise in translating research discoveries into biologics, coupled with the support of the CTSA, will further expand our commitment to developing new diagnostics and vaccines for the neglected infections of poverty that affect children right here in our nation's capital."

The Clinical and Translational Science Institute was created in 2008 as a partnership between Children's National Medical Center and The George Washington University. Its work focuses on three main areas:

  • Diseases of childhood, such as cancer, birth defects, developmental disabilities, asthma;
  • Childhood diseases that persist into adulthood, or adults living with childhood diseases long termfor example congenital heart disease, cystic fibrosis, and muscular dystrophy; and,
  • Diseases of adulthood that begin in childhood and are worsened or develop with age, such as hypertension, type 2 diabetes, and obesity.

This NIH CTSA will help build the infrastructure to achieve the Institute's goals, which include:

  • Designing effective, efficient, systems that encourage research collaboration across disciplines, track effectiveness, and report results;
  • Addressing health disparities and promoting diverse collaborations among pediatric research teams;
  • Promoting multi-disciplinary team science, and growing collaborations with community partners to tackle pressing pediatric health issues; and,
  • Building better education and training for those interested in translational and collaborative approaches to pediatric research.

"We're grateful to the National Center for Research Resources for recognizing the importance of fostering research programs that are designed to address health issues on multiple levels at once, especially in pediatrics," said Mark Batshaw, MD, Chief Academic Officer at Children's National. "As we've learned through our collaborative models in diseases like asthma, when it comes to pediatric health, particularly in urban health settings, the team science model is most successful at ensuring that families who need innovative treatments can access them sooner."

The national CTSA consortium aims to improve human health by transforming the research and training environment to enhance the efficiency and quality of clinical and translational research. The Clinical and Translational Science Institute at Children's National is one of only nine awards given this year.


'/>"/>

Contact: Jennifer Leischer
jleische@cnmc.org
202-476-4500
Children's National Medical Center
Source:Eurekalert

Related medicine news :

1. Parents Want Electronic Access to Their Childrens Docs: Survey
2. HIV care providers and researchers applaud release of national HIV/AIDS strategy
3. Case Western Reserve University named International Center of Excellence for Malaria Research
4. Civil society and local partners for XIX International AIDS Conference (AIDS 2012) announced
5. Online coverage of XVIII International AIDS Conference to include daily webcasts, live coverage, podcasts and news recaps
6. HCL International: Australia a Favourite Destination for UK Social Workers and GPs
7. Nick Jonas to be National Chair of JDRF's Walk to Cure Diabetes
8. NIH funds 10 international centers of excellence for malaria research
9. International AIDS training and research program awarded $3.6 million from NIH
10. Decline in international medical graduates exacerbates shortage of general surgeons
11. Elsevier and International Society of Geriatric Oncology launch Journal of Geriatric Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , ... March 28, 2017 , ... The Radiology ... FRBMA, has begun to serve as its new executive director. Mr. Still was selected ... Search Committee. , “Bob, as he is known to our members, has been ...
(Date:3/28/2017)... ... March 28, 2017 , ... With less than 10,000 dermatologists in the United ... can be limited while the desire to conquer breakouts and eliminate skincare stress is ... every customer online, today released its inaugural survey on the State of Acne in ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive ... “perfect smile.” The National Association of Dental Laboratories (NADL) is informing dentists about ... aware of when utilizing dental laboratories and technicians that create these veneers. ...
(Date:3/28/2017)... ... , ... With expansion and efficiency in mind, Patten Seed Company completed relocation ... plant opened in Marshallville in 2006, and a bagging and shipping facility has been ... of Patten Seed operations to the Middle Georgia location from their previous home in ...
(Date:3/28/2017)... ... ... “A Prophets Bones”: a thrilling adventure that reveals the mystery of Kevin’s purpose. “A Prophets ... parents and teachers had asked of him that he had neglected to do, but this ... Almighty Creator. There were some who would have felt themselves to be special and better ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017 The National University of ... data analytics company, signed a Memorandum of Understanding ... delivery in the region. Under ... Research and Technology (BIGHEART) at NUS and Holmusk ... related to healthcare IT and medical device development. ...
(Date:3/27/2017)... , March 27, 2017 ... specialty clinical-stage pharmaceutical company specializing in the development of ... public offering in the United States ... each ADS representing 40 ordinary shares of the ... In addition, Therapix has granted the underwriters a ...
(Date:3/27/2017)... Calif. , March 27, 2017  Cryoport, Inc. ... that it intends to offer shares of common stock ... registration statement on file with the Securities and Exchange ... and other conditions, and there can be no assurance ... completed, or as to the actual size or terms ...
Breaking Medicine Technology: